• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    5.817 +0.967 (+19.94%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 20
    ...
    23 24 Next >
    News headline image
    Splash Beverage Group And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
    The Dow Jones closed lower by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket ↗
    Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday. 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
    We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning! 
    Via InvestorPlace
    News headline image
    CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
    Via ACCESSWIRE
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Global Trial Targets Unmet Medical Need in Arresting GBM Brain Cancer
    Via Investor Brand Network
    Study Explores Effects of MRI Scans During Cancer Treatment
    Via Investor Brand Network
    News headline image
    Why iMedia Brands Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket ↗
    Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) jumped 119.6% to $1.96 in pre-market trading. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win. 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    Pre-market stock movers are a hot topic on Wednesday as we dive into all of the latest news affecting markets this morning. 
    Via InvestorPlace
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Enrolls First Patient in Switzerland in Its Potentially Pivotal Global GBM Trial, Reports No Exposure to SVB Issues
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Enrolls Over 100 Patients in Potentially Pivotal Berubicin Study
    Via Investor Brand Network
    News headline image
    Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
    Via ACCESSWIRE
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Gainers Liquid Media Group Ltd. (NASDAQ: YVR) jumped 88.1% to $0.2719. 
    Via Benzinga
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Adds Italy to Growing Portfolio of Countries for Berubicin Study
    Via Investor Brand Network
    News headline image
    Why CNS Pharmaceuticals Shares Are Trading Higher ↗
    CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares are trading higher by 15.47% to $1.00 after the company announced it received approval from the Competent Authority and the central Ethics Committee in... 
    Via Benzinga
    News headline image
    CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
    Via ACCESSWIRE
    Broad Cancer Analysis Finds Possibility for Tumor Reduction in Nearly All Cancers
    Via Investor Brand Network
    News headline image
    Stocks That Hit 52-Week Lows On Monday ↗
      On Monday, 76 companies set new 52-week lows. 
    Via Benzinga
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FY 2022 Results, Corporate Update
    Via Investor Brand Network
    AI Screens Brain Tumor Genes in Less Than Two Minutes
    Via Investor Brand Network
    Topics Artificial Intelligence
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation in Upcoming Virtual Investor Event
    Via Investor Brand Network
    Lighting Up Malignant Tissues Could Boost Precision of Surgical Removal
    Via Investor Brand Network
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Hits Key Milestone in Global GBM Clinical Trial with the Enrollment of First Patient in Spain
    Via Investor Brand Network
    Normalizing Blood Vessels in Tumors Could Improve Brain Cancer Immunotherapy
    Via Investor Brand Network
    Research Suggests Brain Cancers Could Be Detected Via Blood Tests
    Via Investor Brand Network
    Topics Death
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues
    Via Investor Brand Network
    Study Documents Dangers of Halting Opioid Treatments for Chronic Pain
    Via Investor Brand Network
    < Previous 1 2
    ...
    12 13 14 15 16 17 18 19 20
    ...
    23 24 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.